---
title: "A Glimpse of American Well's Earnings Potential"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275652095.md"
description: "American Well (NYSE:AMWL) is set to announce its quarterly earnings on February 12, 2026, with analysts predicting an EPS of $-1.59. Following a previous EPS miss that caused a 9.5% drop in share price, investors are keen on positive guidance for the next quarter. Currently, shares are trading at $4.41, down 63.34% over the past year. Analyst ratings suggest a consensus outlook, with an average one-year price target yet to be disclosed. Investors should monitor market sentiments closely ahead of the earnings release."
datetime: "2026-02-11T20:01:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275652095.md)
  - [en](https://longbridge.com/en/news/275652095.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275652095.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275652095.md) | [繁體中文](https://longbridge.com/zh-HK/news/275652095.md)


# A Glimpse of American Well's Earnings Potential

American Well (NYSE:AMWL) is preparing to release its quarterly earnings on Thursday, 2026-02-12. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect American Well to report an **earnings per share** (EPS) of $-1.59.

Anticipation surrounds American Well's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

### Earnings History Snapshot

During the last quarter, the company reported an EPS missed by $0.39, leading to a 9.5% drop in the share price on the subsequent day.

Here's a look at American Well's past performance and the resulting price change:

**Quarter**

**Q3 2025**

**Q2 2025**

**Q1 2025**

**Q4 2024**

**EPS Estimate**

\-1.61

\-1.40

\-1.88

\-2.55

**EPS Actual**

\-2.00

\-1.24

\-1.19

\-2.77

**Price Change %**

\-10.00

\-7.00

20.00

\-5.00

![eps graph](https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1770840091_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

### Performance of American Well Shares

Shares of American Well were trading at $4.41 as of February 10. Over the last 52-week period, shares are down 63.34%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

### Analyst Insights on American Well

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on American Well.

Analysts have provided American Well with ratings, resulting in a consensus rating of . The average one-year price target stands at $, suggesting a potential .

To track all earnings releases for American Well visit their earnings calendar on our site.

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### Related Stocks

- [American Well Corporation (AMWL.US)](https://longbridge.com/en/quote/AMWL.US.md)
- [iShares US Healthcare Providers ETF (IHF.US)](https://longbridge.com/en/quote/IHF.US.md)
- [Stt Strt® SPDR® S&P®HlthCrSvcsETF (XHS.US)](https://longbridge.com/en/quote/XHS.US.md)
- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)

## Related News & Research

- [Rising Medical Solutions Achieves Repeat HITRUST (r2) Certification, Demonstrating Ongoing Excellence in Cybersecurity and Data Protection](https://longbridge.com/en/news/279648929.md)
- [HealthTrust Advances the Future of Clinically Aligned Performance at 2026 FAH Conference](https://longbridge.com/en/news/278743138.md)
- [11:46 ETb.well and Samsung Bring "Kill the Clipboard" to Life, Turning Smartphones Into the Front Door of Healthcare](https://longbridge.com/en/news/278584228.md)
- [Balanced Risk/Reward Amid Operational Transition and Macroeconomic Headwinds Supports Hold Rating](https://longbridge.com/en/news/279129553.md)
- [SRx Health Solutions Announces Series B Preferred Private Placement](https://longbridge.com/en/news/279614685.md)